Search Within

CTCR Scholars

  1. "Alexander Drilon"
Formats
  1. Journal Article (17)
  2. Meeting Abstract (17)
  3. Correspondence (1)
  4. Editorial (1)
  5. Review (1)
Groups
  1. Department of Medicine (37)
  2. Hematology-Oncology Fellows (37)
  3. Solid Tumor Oncology Division (37)
  4. Thoracic Oncology (37)
  5. Department of Pathology and Laboratory Medicine (22)
  6. Graduate Medical Education (22)

More Groups

People
  1. Alexander Drilon (37)
  2. Yonina Murciano-Goroff (29)
  3. Bob Li (18)
  4. Charles Rudin (13)
  5. David Jones (10)
  6. Dazhi Liu (10)

More People

Years
  1. 2025 (3)
  2. 2024 (9)
  3. 2023 (7)
  4. 2022 (8)
  5. 2021 (6)
  6. 2020 (4)
Publications
  1. Journal of Clinical Oncology (14)
  2. Clinical Cancer Research (3)
  3. Journal of Thoracic Oncology (3)
  4. Annals of Oncology (2)
  5. Cancer Discovery (2)
  6. British Journal of Cancer (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (15)
  2. American Association for Cancer Research (7)
  3. Elsevier Inc. (5)
  4. Nature Publishing Group (3)
  5. Oxford University Press (3)
  6. Cell Press (1)

More Publishers

Results (37)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Responsiveness of different MET tumour alterations to type I and type II MET inhibitors
    Journal Article

    Murciano-Goroff, Y. R.; Foglizzo, V.; Chang, J.; Rekhtman, N.; Sisk, A. E.; Gibson, J.; Judka, L.; Clemens, K.; Roa, P.; Ahmed, S. S.; more...
    Clinical and Translational Medicine (2025)

    Fulltext@MSK | Save
  • Sarcoid-like reactions in patients treated with checkpoint inhibitors for advanced solid tumors
    Journal Article

    Nykaza, I.; Murciano-Goroff, Y. R.; Desilets, A.; Harada, G.; Postow, M. A.; Callahan, M. K.; Lee, C. H.; Rudin, C. M.; Kelsen, D. P.; Stadler, Z. K.; more...
    The Oncologist (2025)

    Fulltext@MSK | Save
  • Diverse ERBB2/ERBB3 activating alterations and coalterations have implications for HER2/3-targeted therapies across solid tumors
    Journal Article

    Liu, D.; Jee, J.; Drilon, A.; Heilmann, A. M.; Allen, J. M.; Schrock, A. B.; Keller-Evans, R. B.; Li, B. T.
    Cancer Research Communications (2025)

    Fulltext@MSK | Save
  • Persistence and resistance of HER2 amplification after T-DM1 in a basket trial for patients with solid tumors
    Meeting Abstract

    Liu, D.; Arora, K.; Makker, V.; Buonocore, D.; Shen, R.; Yaeger, R.; Ginsberg, M. S.; Yeh, R.; Offin, M. D.; Solit, D.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Early circulating tumor DNA shedding kinetics for prediction of platinum sensitivity in patients with small cell lung cancer
    Journal Article

    Murciano-Goroff, Y. R.; Hui, A. B. Y.; Araujo Filho, J. A.; Hamilton, E. G.; Chabon, J. J.; Moding, E. J.; Bonilla, R. F.; Lebow, E. S.; Gomez, D.; Rimner, A.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Tumor-agnostic genomic and clinical analysis of BRAF fusions identifies actionable targets
    Journal Article

    Chen, M. F.; Yang, S. R.; Tao, J. J.; Desilets, A.; Diamond, E. L.; Wilhelm, C.; Rosen, E.; Gong, Y.; Mullaney, K.; Torrisi, J.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Characterization of diverse targetable ERBB2 alterations in 512,993 patients with solid tumors
    Meeting Abstract

    Liu, D.; Keller-Evans, R. B.; Schrock, A. B.; Drilon, A. E.; Jee, J.; Li, B. T.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Diverging acquired resistance evolutionary pathways in fusion-positive patients treated with tyrosine kinase inhibitors
    Meeting Abstract

    Repetto, M.; Selenica, P.; Gazzo, A.; Richards, A. L.; Reis-Filho, J. S.; Jee, J.; Donoghue, M.; Weigelt, B.; Drilon, A. E.; Choudhury, N. J.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A pan-cancer analysis of SMARCA4 alterations and the unique clinicogenomic characteristics associated with SMARCA4 mutation types
    Meeting Abstract

    Gormally, M.; Repetto, M.; Jee, J.; Chang, J. C.; Selenica, P.; Gazzo, A.; Richards, A. L.; Donoghue, M.; Aghajanian, C.; Reis-Filho, J. S.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Germline and somatic MUTYH mutations: Clinicopathologic and mutational analysis in a pan-cancer cohort
    Meeting Abstract

    Desilets, A.; Repetto, M.; Kemel, Y.; Khurram, A.; Mandelker, D.; Bandlamudi, C.; Novak, B.; Velilla, C.; Selenica, P.; Richards, A. L.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save